Scientists in the UK and Australia have identified three biomarkers, which when they attached to T-cells (part of the immune system) in high numbers prior to anti-retroviral therapy, increase the chance of early rebound.
Scientists in the UK and Australia have identified three biomarkers, which when they attached to T-cells (part of the immune system) in high numbers prior to anti-retroviral therapy, increase the chance of early rebound.
Comments are closed.